Glipizide
- Product NDC
- 70934-391
- 11-digit product format
- 709340391
- Labeler code
- 70934
- Product ID
- 70934-391_adb5b9b5-1e7e-7643-e053-2995a90aaf07
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- NDA020329
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2019-06-05
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-391-30 | 70934039130 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-391-30) | 2020-02-27 | 0000-00-00 | No | No | Current |
| 70934-391-90 | 70934039190 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-391-90) | 2019-06-05 | 0000-00-00 | No | No | Current |